• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidinecarboxylic acids and derivatives Piperidinecarboxylic acids

Introduction to Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate (CAS No. 198422-46-7)

Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate, identified by its Chemical Abstracts Service number CAS No. 198422-46-7, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and drug development. This compound belongs to the piperidine class, a heterocyclic amine characterized by a six-membered ring containing one nitrogen atom. The unique stereochemistry and functional groups present in this molecule make it a promising candidate for various therapeutic applications.

The structural features of Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate include two hydroxymethyl groups at the 2 and 6 positions of the piperidine ring, along with a tert-butyl substituent at the 1-position. This arrangement imparts distinct chemical properties that are critical for its biological activity. The presence of multiple chiral centers, specifically at the 2 and 6 positions with an (R,S) configuration, underscores the compound's potential as a chiral building block in asymmetric synthesis.

In recent years, there has been growing interest in the development of novel piperidine derivatives for their pharmacological properties. Piperidine scaffolds are widely recognized for their role in medicinal chemistry due to their ability to modulate biological targets effectively. The compound Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate represents an advanced derivative with enhanced functionalization, making it a valuable intermediate in the synthesis of more complex molecules.

One of the most compelling aspects of this compound is its potential application in the synthesis of enzyme inhibitors and receptor modulators. The hydroxymethyl groups provide opportunities for further derivatization, allowing chemists to tailor the molecule's properties for specific biological targets. For instance, modifications at these positions can influence solubility, metabolic stability, and binding affinity to biological receptors.

Recent studies have highlighted the importance of stereochemistry in drug design, particularly in the context of enantioselective synthesis. The (R,S) configuration of Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate ensures that any derivatives synthesized from it will retain this specific stereochemical profile. This is crucial because enantiomers often exhibit different pharmacological activities, making stereocontrol a key consideration in drug development.

The tert-butyl group at the 1-position of the piperidine ring contributes to steric hindrance and lipophilicity, which can be exploited to optimize drug-like properties such as bioavailability and membrane permeability. These structural elements are particularly relevant in the design of central nervous system (CNS) drugs, where blood-brain barrier penetration is a critical factor.

Moreover, the hydroxymethyl groups provide sites for hydrogen bonding interactions with biological targets. This feature is particularly useful in designing molecules that require strong binding affinity to proteins or enzymes. Such interactions are essential for therapeutic efficacy and can be fine-tuned through structural modifications.

From a synthetic chemistry perspective, Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate serves as an excellent precursor for constructing more complex piperidine derivatives. Its versatile functional groups allow for a wide range of chemical transformations, including etherification, esterification, and condensation reactions. These synthetic pathways open up numerous possibilities for developing novel compounds with tailored pharmacological profiles.

The compound's potential extends beyond traditional small-molecule drug development. It has shown promise as a building block in peptidomimetics and protein-protein interaction inhibitors. By leveraging its structural features, researchers can design molecules that mimic peptide sequences while avoiding their inherent limitations such as degradation by proteases or poor cell penetration.

In conclusion,Tert-butyl (2R,6S)-2,6-bis(hydroxymethyl)piperidine-1-carboxylate (CAS No. 198422-46-7) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential applications. Its stereochemistry, functional groups, and synthetic versatility make it an invaluable asset in drug discovery efforts aimed at developing novel therapeutics for various diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)